Upregulation of EMID1 Accelerates to a Favorable Prognosis and Immune Infiltration in Lung Adenocarcinoma

Table 2

The characteristics of lung adenocarcinoma patients.

Clinical characteristics		TCGA (N = 522)	%	GEO (N = 61)	%
Age (mean ± SD)		65.33 ± 10.02		59.41 ± 10.41
Survival time (y)		2.11 ± 2.28		2.91 ± 2.44
Gender	Female	280	53.60	28	45.90
	Male	242	46.40	33	54.10
Stage	I	279	53.40
	II	124	23.80
	III	85	16.30
	IV	26	5.00
Tumor status	T1	172	34.30
	T2	281	53.80
	T3	47	9.00
	T4	19	3.60
Lymph node	N0	335	64.20
	N1	98	18.70
	N2	75	14.40
	N3	2	0.40
Distant metastasis	M0	353	67.60
	M1	25	4.80